In another study, Wang et al. confirmed that the expression of RAB34 conferred a poor prognosis in high-grade glioma patients; furthermore, HSPA6 was positively correlated with the expression of RAB34 (Wang et al., 2015). This evidence concerns the gene RAB34 and central nervous system cancer.